Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Found 6558 record(s)

Nothing to report this month

Organization: Exinvest Inc.

February 2025

Req # A-2019-001738

Adverse Drug Reactions (ADRs) for PANTOPRAZOLE SODIUM. Report numbers: E2B_02781670, E2B_02781701, E2B_02785807, E2B_02785829, E2B_02786030, E2B_02786035, E2B_02775045.

Organization: Health Canada

254 page(s)
January 2025

Req # A-2020-000352

Adverse Drug Reactions (ADRs) for INSULIN GLARGINE. Report numbers: 727720, 000728214, 729829, E2B_02748555, E2B_02755215.

Organization: Health Canada

35 page(s)
January 2025

Req # A-2020-001377

Adverse Drug Reactions (ADRs). Report numbers: E2B_02850613, E2B_02850821, E2B_02850858, E2B_02850951, E2B_02851375, E2B_02851993, E2B_02852024, E2B_02852029, E2B_02852113, E2B_02852837, E2B_02852897, E2B_02853599, E2B_02854208, E2B_02854279,…

Organization: Health Canada

306 page(s)
January 2025

Req # A-2020-001378

Adverse Drug Reactions (ADRs). Report numbers: E2B_02862159, E2B_02862257, E2B_02862291, E2B_02862812, E2B_02863394, E2B_02864513, E2B_02864648, E2B_02865118, E2B_02865433, E2B_02865511, E2B_02865512, E2B_02865556, E2B_02865678, E2B_02866678,…

Organization: Health Canada

331 page(s)
January 2025

Req # A-2020-001637

Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_03262131, E2B_03262541, E2B_03238488, E2B_03262564, E2B_03264812, E2B_03265184, E2B_03266801, E2B_03267081, E2B_03267270, E2B_03267898, E2B_03269596, E2B_03269992, E2B_03271101,…

Organization: Health Canada

603 page(s)
January 2025

Req # A-2020-001668

Adverse Drug Reactions (ADRs). Report numbers: 000921252, 000926298, 03346783, E2B_03356699, E2B_03381172, E2B_03390760, E2B_03395953, E2B_03396613, E2B_03405398, and E2B_03405486.

Organization: Health Canada

254 page(s)
January 2025

Req # A-2021-000395

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-102144-952, COVID Alert App Advisory Council First Interim Report.

Organization: Health Canada

31 page(s)
January 2025

Req # A-2021-001016

Adverse Drug Reaction (ADR) for ANTI-THYMOCYTE GLOBULIN (RABBIT). Report number: E2B_03960400.

Organization: Health Canada

18 page(s)
January 2025

Req # A-2021-001150

Adverse Drug Reaction (ADR) for TERIFLUNOMIDE. Report number: E2B_03954332.

Organization: Health Canada

15 page(s)
January 2025
Date modified: